Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

Jingwen Liu; Holger Grohganz; Korbinian Lobmann; Thomas Rades; Nele-Johanna Hempel

doi:10.3390/pharmaceutics13030389

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

Jingwen Liu, Holger Grohganz, Korbinian Lobmann, Thomas Rades, Nele-Johanna Hempel

Publikation: Bidrag til tidsskrift › Review › Forskning

97 Citationer (Scopus)

55 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	389
Tidsskrift	Pharmaceutics
Vol/bind	13
Udgave nummer	3
Antal sider	43
ISSN	1999-4923
DOI	https://doi.org/10.3390/pharmaceutics13030389
Status	Udgivet - 2021

Adgang til dokumentet

10.3390/pharmaceutics13030389Licens: CC BY

pharmaceutics-13-00389Forlagets udgivne version, 3,98 MBLicens: CC BY

Citationsformater

Liu, J., Grohganz, H., Lobmann, K., Rades, T., & Hempel, N-J. (2021). Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics, 13(3), [389]. https://doi.org/10.3390/pharmaceutics13030389

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. / Liu, Jingwen; Grohganz, Holger ; Lobmann, Korbinian ; Rades, Thomas; Hempel, Nele-Johanna.

I: Pharmaceutics, Bind 13, Nr. 3, 389, 2021.

Publikation: Bidrag til tidsskrift › Review › Forskning

Liu, J, Grohganz, H , Lobmann, K , Rades, T & Hempel, N-J 2021, 'Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies', Pharmaceutics, bind 13, nr. 3, 389. https://doi.org/10.3390/pharmaceutics13030389

Liu J, Grohganz H , Lobmann K , Rades T, Hempel N-J. Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. Pharmaceutics. 2021;13(3). 389. https://doi.org/10.3390/pharmaceutics13030389

Liu, Jingwen ; Grohganz, Holger ; Lobmann, Korbinian ; Rades, Thomas ; Hempel, Nele-Johanna. / Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies. I: Pharmaceutics. 2021 ; Bind 13, Nr. 3.

@article{a905f281192042e48bc3b149876ba083,

title = "Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies",

keywords = "co-amorphous, poorly water soluble drugs, solid dispersion, co-formability, in vivo studies, physical stability, molar ratio optimization",

author = "Jingwen Liu and Holger Grohganz and Korbinian Lobmann and Thomas Rades and Nele-Johanna Hempel",

year = "2021",

doi = "10.3390/pharmaceutics13030389",

language = "English",

volume = "13",

journal = "Pharmaceutics",

issn = "1999-4923",

publisher = "MDPI AG",

number = "3",

}

TY - JOUR

T1 - Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

AU - Liu, Jingwen

AU - Grohganz, Holger

AU - Lobmann, Korbinian

AU - Rades, Thomas

AU - Hempel, Nele-Johanna

PY - 2021

Y1 - 2021

KW - co-amorphous

KW - poorly water soluble drugs

KW - solid dispersion

KW - co-formability

KW - in vivo studies

KW - physical stability

KW - molar ratio optimization

U2 - 10.3390/pharmaceutics13030389

DO - 10.3390/pharmaceutics13030389

M3 - Review

C2 - 33804159

VL - 13

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 3

M1 - 389

ER -